Erfonrilimab Antibody
Erfonrilimab (KN-046) is a bispecific monoclonal antibody designed to simultaneously block the PD-L1 and CTLA-4 immune checkpoints. It is utilized in preclinical research to investigate antitumor immunity and efficacy in various in vitro and in vivo cancer models.
Product Specifications
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2076324-01 0.1 mL
HRP-Linked Polyclonal Antibody to Crystallin Beta B1 (CRYbB1)
Sign In for Pricing
View Details MBS2076324-02 0.2 mL
HRP-Linked Polyclonal Antibody to Crystallin Beta B1 (CRYbB1)
Sign In for Pricing
View Details MBS2076324-03 0.5 mL
HRP-Linked Polyclonal Antibody to Crystallin Beta B1 (CRYbB1)
Sign In for Pricing
View Details MBS2076324-04 1 mL
HRP-Linked Polyclonal Antibody to Crystallin Beta B1 (CRYbB1)
Sign In for Pricing
View Details MBS2076324-05 5 mL
HRP-Linked Polyclonal Antibody to Crystallin Beta B1 (CRYbB1)
Sign In for Pricing
View Details 